Corbus Pharmaceuticals
CRBP
$38.77
Share price
1.49%
Change (1 day)
268.89%
Change (1 year)
Categories
Operating Margin for Corbus Pharmaceuticals (CRBP)
Operating Margin as of May 2024 (TTM): -5,176.38%
According to Corbus Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -5,176.38%. At the end of 2021 the company had an Operating Margin of -5,176.38%.
Operating Margin history for Corbus Pharmaceuticals from 2016 to 2021
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -5,176.38% | 83.16% |
| 2020 | -2,826.08% | 1329.52% |
| 2019 | -197.69% | -82.88% |
| 2018 | -1,154.48% | -13.11% |
| 2017 | -1,328.65% | 26.99% |
| 2016 | -1,046.27% | -23.35% |
| 2015 | -1,365.05% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | 0.00% | N/A | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | 6.23% | -100.12% | 🇺🇸 USA |
 Epizyme EPZM | 0.00% | N/A | 🇺🇸 USA |
 Advaxis ADXS | -549.75% | -89.38% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.